A Double-Blind, Randomized, Controlled, Multicenter Study to Evaluate the Safety, Tolerability and Immunogenicity of a Refrigerator-Stable Formulation of Zoster Vaccine Live (Oka/Merck).
Phase of Trial: Phase III
Latest Information Update: 04 Apr 2014
At a glance
- Drugs Varicella zoster virus vaccine live (Primary)
- Indications Herpes zoster
- Focus Pharmacodynamics; Registrational
- Sponsors Merck Sharp & Dohme
- 01 Feb 2008 Status changed from active, no longer recruiting to completed as reported in the Clinical and Vaccine Immunology.
- 10 Nov 2005 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History